Avocado-soybean unsaponifiables (ASU)

Standardised fixed-ratio extract: manufacturer-funded trials show small, variable reductions in hip and knee osteoarthritis pain, with no slowing of joint-space loss on the main measure.

Evidence
Preliminary evidenceGRADE certainty: Low
Typical dose
300 mg/day as a single capsule
Time to effect
Symptoms were assessed over several months
Safety
Has documented cautions

Evidence ratings summarise published research on Avocado-soybean unsaponifiables (ASU) in general. They are not a health claim for any product and not advice for any individual. Talk to your doctor before starting anything new, especially if you take medication.

Ask about Avocado-soybean unsaponifiables (ASU)

Interactions

Taking any medication?

Check Avocado-soybean unsaponifiables (ASU) against it.

Why

Avocado-soybean unsaponifiables (ASU) in a 1:2 ratio, licensed as a medicine in some European countries. The Christensen 2008 meta-analysis of four manufacturer-funded trials (n=664) found 300 mg/day reduced pain versus placebo, but results varied widely between trials. In the 3-year ERADIAS trial in hip osteoarthritis, mean joint-space loss did not differ from placebo (fewer participants progressed, 40% vs 50%) and clinical outcomes did not differ.

How it works

Unsaponifiable fraction includes phytosterols (β-sitosterol) and tocopherols. In laboratory studies, inhibits IL-1β-induced chondrocyte metalloproteinase (MMP-3, MMP-13) expression and stimulates collagen type-II synthesis. Mechanism distinct from NSAIDs (no COX inhibition) and from glucosamine.

Expected onset · Symptoms were assessed over several months; the 3-year trial showed no difference in joint-space loss

How to take

Dosage

300 mg/day as a single capsule. Continuous use over 3+ months for symptomatic benefit; longer for structural effect.

Timing

Once daily with the main meal

On the label

ASU 300 mg with a stated 1:2 avocado:soy ratio, as used in the trials.

Studied in

Adults with symptomatic hip or knee osteoarthritis, particularly when NSAIDs are poorly tolerated.

Safety

Side effects reported in trials were mostly mild GI upset. Theoretical antiplatelet effect at very high doses. Pregnancy and breastfeeding: limited data; avoid medicinal doses. Soy allergy: rare reactions reported. Interaction data are limited.
Loading interactions…

Evidence

At a glance

Christensen 2008 Osteoarthritis Cartilage meta-analysis (four manufacturer-funded trials, n=664; hip and knee osteoarthritis): 300 mg/day ASU reduced pain versus placebo, but results varied widely between trials. In the 3-year ERADIAS RCT (Maheu 2014 Ann Rheum Dis, n=399, hip osteoarthritis), mean joint-space loss did not differ from placebo, though fewer participants progressed (40% vs 50%), and clinical outcomes did not differ.

GRADE certainty: Low — rated by Healicus using the GRADE method

Questions people ask

Does Avocado-soybean unsaponifiables (ASU) work?

Christensen 2008 Osteoarthritis Cartilage meta-analysis (four manufacturer-funded trials, n=664; hip and knee osteoarthritis): 300 mg/day ASU reduced pain versus placebo, but results varied widely between trials. In the 3-year ERADIAS RCT (Maheu 2014 Ann Rheum Dis, n=399, hip osteoarthritis), mean joint-space loss did not differ from placebo, though fewer participants progressed (40% vs 50%), and clinical outcomes did not differ. Certainty of the evidence: Low, rated by Healicus using the GRADE method.

How is Avocado-soybean unsaponifiables (ASU) taken?

300 mg/day as a single capsule. Continuous use over 3+ months for symptomatic benefit; longer for structural effect. Timing: Once daily with the main meal. Ranges are those reported in the cited sources, not individual advice; talk to your doctor or pharmacist before starting, especially if you take medication.

Are there interactions or cautions?

Side effects reported in trials were mostly mild GI upset. Theoretical antiplatelet effect at very high doses. Pregnancy and breastfeeding: limited data; avoid medicinal doses. Soy allergy: rare reactions reported. Interaction data are limited. Documented drug and supplement interactions can be looked up in the free interaction reference.

What is the evidence based on?

Sources: Christensen R et al., Symptomatic efficacy of avocado-soybean unsaponifiables (ASU) in osteoarthritis (OA) patients: a meta-analysis of randomized controlled trials, Osteoarthritis Cartilage 2008; Maheu E et al., Randomised, controlled trial of avocado-soybean unsaponifiable effect on structure modification in hip osteoarthritis: the ERADIAS study, Ann Rheum Dis 2014.

One evidence finding a day, like this one: follow Healicus on Threads or Bluesky.